TECH vs. PFE
TECH (Bio-Techne Corporation) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — TECH in Biotechnology, PFE in Drug Manufacturers - General. Over the past 10 years, TECH returned 7.82%/yr vs 1.96%/yr for PFE. At a 0.28 correlation, their price movements are largely independent.
Performance
TECH vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TECH achieves a -5.14% return, which is significantly lower than PFE's 4.10% return. Over the past 10 years, TECH has outperformed PFE with an annualized return of 7.82%, while PFE has yielded a comparatively lower 1.96% annualized return.
TECH
- 1D
- -4.02%
- 1M
- 15.35%
- YTD
- -5.14%
- 6M
- -5.38%
- 1Y
- 12.14%
- 3Y*
- -9.63%
- 5Y*
- -12.52%
- 10Y*
- 7.82%
PFE
- 1D
- -0.52%
- 1M
- -3.17%
- YTD
- 4.10%
- 6M
- 2.82%
- 1Y
- 11.94%
- 3Y*
- -7.59%
- 5Y*
- -3.66%
- 10Y*
- 1.96%
TECH vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TECH Bio-Techne Corporation | -5.14% | -17.89% | -6.13% | -6.49% | -35.69% | 63.40% | 45.40% | 52.67% | 12.60% | 27.40% |
PFE Pfizer Inc. | 4.10% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between TECH and PFE is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.40 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Dec 9, 1992 | 0.28 |
The correlation between TECH and PFE shifts across timeframes, from 0.28 (all time) to 0.45 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TECH:
$8.73B
PFE:
$143.73B
TECH:
$0.70
PFE:
$1.31
TECH:
79.44
PFE:
19.11
TECH:
7.19
PFE:
2.26
TECH:
4.14
PFE:
1.60
TECH:
$1.21B
PFE:
$63.32B
TECH:
$786.49M
PFE:
$43.91B
TECH:
$176.43M
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TECH vs. PFE — Risk / Return Rank
TECH
PFE
TECH vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TECH | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.24 | ||
| Sortino ratioReturn per unit of downside risk | -0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.11 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.31 | 1.05 | -0.73 |
| Martin ratioReturn relative to average drawdown | 0.74 | 2.06 | -1.32 |
Loading charts...
Drawdowns
TECH vs. PFE - Drawdown Comparison
The maximum TECH drawdown since its inception was -74.39%, which is greater than PFE's maximum drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for TECH and PFE.
Loading charts...
Drawdown Indicators
| TECH | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.39% | -69.24% | -5.15% |
Max Drawdown (1Y)Largest decline over 1 year | -39.25% | -11.47% | -27.78% |
Max Drawdown (3Y)Largest decline over 3 years | -50.85% | -37.69% | -13.16% |
Max Drawdown (5Y)Largest decline over 5 years | -67.18% | -58.96% | -8.22% |
Max Drawdown (10Y)Largest decline over 10 years | -67.18% | -58.96% | -8.22% |
Current DrawdownCurrent decline from peak | -57.77% | -48.02% | -9.75% |
Average DrawdownAverage peak-to-trough decline | -24.15% | -22.91% | -1.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.41% | 5.80% | +10.61% |
Volatility
TECH vs. PFE - Volatility Comparison
Bio-Techne Corporation (TECH) has a higher volatility of 12.87% compared to Pfizer Inc. (PFE) at 5.40%. This indicates that TECH's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TECH | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.87% | 5.40% | +7.47% |
Volatility (6M)Calculated over the trailing 6-month period | 36.63% | 14.21% | +22.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.31% | 23.93% | +22.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.82% | 25.50% | +13.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.05% | 23.91% | +10.14% |
Dividends
TECH vs. PFE - Dividend Comparison
TECH's dividend yield for the trailing twelve months is around 0.58%, less than PFE's 6.86% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.86% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
TECH Bio-Techne Corporation | 0.58% | 0.54% | 0.56% | 0.41% | 0.39% | 0.25% | 0.40% | 0.58% | 0.88% | 0.99% | 1.24% | 1.42% |
Financials
TECH vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Bio-Techne Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TECH vs. PFE - Profitability Comparison
TECH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bio-Techne Corporation reported a gross profit of 208.29M and revenue of 311.42M. Therefore, the gross margin over that period was 66.9%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
TECH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bio-Techne Corporation reported an operating income of 75.50M and revenue of 311.42M, resulting in an operating margin of 24.2%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
TECH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bio-Techne Corporation reported a net income of 51.05M and revenue of 311.42M, resulting in a net margin of 16.4%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
TECH and PFE have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TECH has higher volatility (12.87%) compared to PFE (5.40%). In terms of maximum drawdown, TECH dropped -74.39% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.50 vs 0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TECH and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer